Alcon [ALC] vs Hologic [HOLX] Detailed Stock Comparison
Alcon
NYSE
Loading...
Hologic
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Alcon wins in 6 metrics, Hologic wins in 13 metrics, with 0 ties. Hologic appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alcon | Hologic | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 40.84 | 27.76 | Hologic |
| Price-to-Book Ratio | 2.07 | 3.07 | Alcon |
| Debt-to-Equity Ratio | 23.63 | 52.09 | Alcon |
| PEG Ratio | 26.11 | 14.17 | Hologic |
| EV/EBITDA | 21.16 | 12.43 | Hologic |
| Profit Margin (TTM) | 11.28% | 13.79% | Hologic |
| Operating Margin (TTM) | 13.30% | 25.48% | Hologic |
| EBITDA Margin (TTM) | 13.30% | 25.48% | Hologic |
| Return on Equity | 5.23% | 11.38% | Hologic |
| Return on Assets (TTM) | 2.74% | 6.69% | Hologic |
| Free Cash Flow (TTM) | $1.41B | $1.15B | Alcon |
| 1-Year Return | -7.73% | -18.63% | Alcon |
| Price-to-Sales Ratio (TTM) | 4.62 | 3.68 | Hologic |
| Enterprise Value | $49.36B | $15.52B | Alcon |
| EV/Revenue Ratio | 4.97 | 3.84 | Hologic |
| Gross Profit Margin (TTM) | 55.92% | 56.32% | Hologic |
| Revenue per Share (TTM) | $20 | $18 | Alcon |
| Earnings per Share (Diluted) | $2.25 | $2.41 | Hologic |
| Beta (Stock Volatility) | 0.70 | 0.49 | Hologic |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alcon vs Hologic Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alcon | 0.35% | -2.41% | -1.49% | -10.57% | -3.95% | 2.76% |
| Hologic | 0.19% | 1.34% | 4.87% | 21.15% | 4.32% | -5.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alcon | -7.73% | 22.36% | 39.35% | 57.52% | 57.52% | 57.52% |
| Hologic | -18.63% | -6.75% | 1.87% | 60.33% | 361.11% | 493.89% |
Performance & Financial Health Analysis: Alcon vs Hologic
| Metric | ALC | HOLX |
|---|---|---|
| Market Information | ||
| Market Cap | $45.84B | $14.88B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,498,680 | 1,830,700 |
| 90 Day Avg. Volume | 1,604,603 | 1,903,103 |
| Last Close | $85.75 | $68.06 |
| 52 Week Range | $80.48 - $101.10 | $51.90 - $84.67 |
| % from 52W High | -15.18% | -19.62% |
| All-Time High | $101.10 (Sep 09, 2024) | $87.88 (May 01, 2023) |
| % from All-Time High | -15.18% | -22.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.01% |
| Quarterly Earnings Growth | 0.41% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.14% |
| Operating Margin (TTM) | 0.13% | 0.25% |
| Return on Equity (TTM) | 0.05% | 0.11% |
| Debt to Equity (MRQ) | 23.63 | 52.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $44.39 | $21.79 |
| Cash per Share (MRQ) | $2.85 | $8.47 |
| Operating Cash Flow (TTM) | $2.12B | $1.07B |
| Levered Free Cash Flow (TTM) | $1.18B | $760.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Alcon vs Hologic
| Metric | ALC | HOLX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 40.84 | 27.76 |
| Forward P/E | 26.11 | 14.17 |
| PEG Ratio | 26.11 | 14.17 |
| Price to Sales (TTM) | 4.62 | 3.68 |
| Price to Book (MRQ) | 2.07 | 3.07 |
| Market Capitalization | ||
| Market Capitalization | $45.84B | $14.88B |
| Enterprise Value | $49.36B | $15.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.97 | 3.84 |
| Enterprise to EBITDA | 21.16 | 12.43 |
| Risk & Other Metrics | ||
| Beta | 0.70 | 0.49 |
| Book Value per Share (MRQ) | $44.39 | $21.79 |
Financial Statements Comparison: Alcon vs Hologic
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALC | HOLX |
|---|---|---|
| Revenue/Sales | $2.47B | $1.01B |
| Cost of Goods Sold | $1.09B | $628.00M |
| Gross Profit | $1.38B | $377.30M |
| Research & Development | $222.00M | $61.50M |
| Operating Income (EBIT) | $468.00M | $37.90M |
| EBITDA | $463.00M | $121.70M |
| Pre-Tax Income | $414.00M | $-28.50M |
| Income Tax | $64.00M | $-11.10M |
| Net Income (Profit) | $350.00M | $-17.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALC | HOLX |
|---|---|---|
| Cash & Equivalents | $1.41B | $1.43B |
| Total Current Assets | $6.07B | $3.21B |
| Total Current Liabilities | $2.25B | $989.70M |
| Long-Term Debt | $5.02B | $2.47B |
| Total Shareholders Equity | $22.02B | $4.62B |
| Retained Earnings | N/A | $3.03B |
| Property, Plant & Equipment | $4.90B | $939.80M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALC | HOLX |
|---|---|---|
| Operating Cash Flow | N/A | $28.40M |
| Capital Expenditures | N/A | $-24.70M |
| Free Cash Flow | $384.00M | $129.20M |
| Debt Repayment | N/A | $-10.20M |
| Common Stock Repurchase | N/A | $-200.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ALC | HOLX |
|---|---|---|
| Shares Short | 6.89M | 5.15M |
| Short Ratio | 4.54 | 2.16 |
| Short % of Float | N/A | 0.03% |
| Average Daily Volume (10 Day) | 1,498,680 | 1,830,700 |
| Average Daily Volume (90 Day) | 1,604,603 | 1,903,103 |
| Shares Outstanding | 494.62M | 231.73M |
| Float Shares | 494.60M | 220.31M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.69% | 1.04% |
Dividend Analysis & Yield Comparison: Alcon vs Hologic
| Metric | ALC | HOLX |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.17 | N/A |
| 3-Year Avg Dividend Yield | 0.30% | N/A |
| 3-Year Total Dividends | $0.50 | N/A |
| Ex-Dividend Date | May 14, 2024 | N/A |